Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: rarely (96), occasionally (196), seldom (7)

First seizure - patient information

Description: This leaflet contains important information about having a seizure for the first time.
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/First-seizure-1641-PIL.pdf

Capecitabine-Carboplatin(AUC5)-Cetuximab

Description: Chemotherapy Protocol HEAD AND NECK CANCER CAPECITABINE-CARBOPLATIN (AUC5)-CETUXIMAB Reg
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Capecitabine-Carboplatin-Cetuximab.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Re
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

InP (RICE) Carboplatin Etoposide Ifosfamide Rituximab

Description: Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Inpatient Regimen Regimen • Lymphoma – InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin’s Ly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab.pdf

AmB Carboplatin Etoposide Ifosfamide Rituximab (RICE)

Description: Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Ambulatory Regimen Regimen • Lymphoma – AmB-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin’s L
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-Carboplatin-Etoposide-Ifosfamide-Rituximab-RICE-Ver1.1.pdf

Bevacizumab (7.5mgkg), Carboplatin(AUC5) and Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (7.5)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Ovary-Bevacizumab (7.5)-C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab7.5mgkgCarboplatinandPaclitaxel21day.pdf

Diarrhoea - patient information

Description: Patient information factsheet Diarrhoea Diarrhoea is passing looser or more frequent stools than is normal for you. It
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Diarrhoea-1360-PIL.pdf

Headache - patient information

Description: Patient information factsheet Headache More than 10 million people in the UK get headaches regularly, making them one
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Headache-1361-PIL.pdf

Urinary tract infection - patient information

Description: Patient information factsheet Urinary tract infections (UTIs) Urinary tract infections (UTIs) are very common. They can b
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Urinary-tract-infection-1359-PIL.pdf

Atezolizumab-Bevacizumab-Carboplatin(AUC6)-Paclitaxel

Description: Chemotherapy Protocol LUNG CANCER ATEZOLIZUMAB-BEVACIZUMAB-CARBOPLATIN (AUC6)-PACLITAXEL Regimen  Lung-Atezolizumab-Bevacizumab-Carbopl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab-Bevacizumab-CarboplatinAUC6-Paclitaxel.pdf

331 to 340 of 560

Previous … 32 33 34 35 36 … Next